These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10634656)

  • 1. Pathology of lung cancer.
    Franklin WA
    J Thorac Imaging; 2000 Jan; 15(1):3-12. PubMed ID: 10634656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia.
    Franklin WA
    Chest; 2000 Apr; 117(4 Suppl 1):80S-89S. PubMed ID: 10777460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Classification of broncho-pulmonary cancers (WHO 1999)].
    Brambilla E
    Rev Mal Respir; 2002 Sep; 19(4):455-66. PubMed ID: 12417862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary preneoplasia.
    Dacic S
    Arch Pathol Lab Med; 2008 Jul; 132(7):1073-8. PubMed ID: 18605763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical markers of cancerogenesis in the lung.
    Pankiewicz W; Minarowski L; Niklińska W; Naumnik W; Nikliński J; Chyczewski L
    Folia Histochem Cytobiol; 2007; 45(2):65-74. PubMed ID: 17597018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new World Health Organization classification of lung tumours.
    Brambilla E; Travis WD; Colby TV; Corrin B; Shimosato Y
    Eur Respir J; 2001 Dec; 18(6):1059-68. PubMed ID: 11829087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
    Travis WD; Garg K; Franklin WA; Wistuba II; Sabloff B; Noguchi M; Kakinuma R; Zakowski M; Ginsberg M; Padera R; Jacobson F; Johnson BE; Hirsch F; Brambilla E; Flieder DB; Geisinger KR; Thunnissen F; Kerr K; Yankelevitz D; Franks TJ; Galvin JR; Henderson DW; Nicholson AG; Hasleton PS; Roggli V; Tsao MS; Cappuzzo F; Vazquez M
    J Thorac Oncol; 2006 Nov; 1(9 Suppl):S13-9. PubMed ID: 17409995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
    Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
    J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
    Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
    Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
    Rouquette Lassalle I
    Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological aspects of carcinogenesis in the lung.
    Chyczewski L; Niklinski J; Chyczewska E; Niklinska W; Naumnik W
    Lung Cancer; 2001 Dec; 34 Suppl 2():S17-25. PubMed ID: 11720737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary preneoplasia--sequential molecular carcinogenetic events.
    Lantuéjoul S; Salameire D; Salon C; Brambilla E
    Histopathology; 2009 Jan; 54(1):43-54. PubMed ID: 19187179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer: developments, concepts, and specific aspects of the new WHO classification.
    Petersen I; Warth A
    J Cancer Res Clin Oncol; 2016 May; 142(5):895-904. PubMed ID: 26197868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
    Schnabel PA; Junker K
    Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of p53 protein in neoplastic, preneoplastic and normal bronchial mucosa specimens obtained during diagnostic bronchoscopy.
    Orfanidou D; Kalomenidis J; Rasidakis A; Papamichalis G; Toumbis M; Labaditis J; Sacharidou A; Papastamatiou H; Jordanoglou J
    Oncol Rep; 1998; 5(3):763-9. PubMed ID: 9538190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of the airways and pulmonary parenchyma of patients at risk for a second lung cancer.
    Means-Markwell M; Linnoila RI; Williams J; Jänne PA; Kaye F; O'Neil K; Johnson BE
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5915-21. PubMed ID: 14676115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].
    Warth A
    Pathologe; 2015 Nov; 36 Suppl 2():194-200. PubMed ID: 26391251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary preinvasive neoplasia.
    Kerr KM
    J Clin Pathol; 2001 Apr; 54(4):257-71. PubMed ID: 11304841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistological comparison of the World Health Organization (WHO) and Ljubljana classifications on the grading of preneoplastic lesions of the larynx.
    Sengiz S; Pabuççuoğlu U; Sarioğlu S
    Pathol Res Pract; 2004; 200(3):181-8. PubMed ID: 15200269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of small foci of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) with adenocarcinoma of the lung.
    Mireskandari M; Abdirad A; Zhang Q; Dietel M; Petersen I
    Pathol Res Pract; 2013 Sep; 209(9):578-84. PubMed ID: 23988499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.